Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04798261 · ClinicalTrials.gov registry record
Study of the Long-Term Safety and Outcomes of Treating Pulmonary Embolism With the Indigo Aspiration System
A clinical trial of Pulmonary Embolism, sponsored by Penumbra.
- Recruiting
- Registry status
- 1,500
- Enrollment target
- 20
- Study locations
NCT04798261 is a study of Pulmonary Embolism that is actively recruiting participants, run by Penumbra. The registered enrollment target is 1,500 participants, below the 3,027-participant average among 48 other Pulmonary Embolism trials with a reported enrollment target (50% lower). The trial reports 20 study locations across 5 states.
The verdict
NCT04798261, a study of Pulmonary Embolism, is actively recruiting participants, sponsored by Penumbra.
- RECRUITING
- Registry status
- 1,500 participants
- Enrollment target
- 20
- Study locations
Study Summary
The objective of this study is to evaluate real world long-term functional outcomes, safety and performance of the Indigo Aspiration System for the treatment of pulmonary embolism (PE).
Conditions Studied
Interventions
- DEVICE Indigo Aspiration System
Study Locations (20)
Florida
- Manatee Memorial Hospital - Bradenton
- Blake Medical Center/Nova Clinical Research - Brandenton
- Delray Medical Center, Inc. - Delray Beach
- University of Florida Shands Hospital - Gainesville
- Radiology and Imaging Specialists - Lakeland
- Jackson Memorial Hospital - Miami
- Baptist Health Miami Cardiac and Vascular Institute - Miami
- AdventHealth Orlando - Orlando
- HCA Florida Northside Hospital - Petersburg
- Tampa General Hospital - Tampa
- St. Joseph Hospital - BayCare - Tampa
California
- Long Beach Medical Center - Long Beach
- Cedars-Sinai Medical Center - Los Angeles
- UCLA Medical Center - Los Angeles
- UC Irvine Medical Center - Orange
- Sharp Memorial Hospital - San Diego
Illinois
- Memorial Hospital Belleville - Belleville
- Loyola University Medical Center - Maywood
Delaware
- Christiana Care Hospital - Newark
Georgia
- University Hospital Augusta - Augusta
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,500 participants |
| Start Date | 2021-06-25 |
| Est. Completion | 2028-02 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04798261
The ClinicalTrials.gov registry entry for NCT04798261 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 1,500 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 3,027-participant average among 48 other Pulmonary Embolism trials with a reported enrollment target (50% lower). The listed sponsor is Penumbra, which has 25 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Pulmonary Embolism appearing as the primary indexed condition, and to 1 intervention - of which Indigo Aspiration System is the first listed.
NCT04798261 reports 20 study locations spanning 5 distinct geographic areas - top geographies include Florida, California, Illinois.
Frequently Asked Questions
What is clinical trial NCT04798261 about?
NCT04798261 is a clinical study titled "Study of the Long-Term Safety and Outcomes of Treating Pulmonary Embolism With the Indigo Aspiration System". The objective of this study is to evaluate real world long-term functional outcomes, safety and performance of the Indigo Aspiration System for the treatment of pulmonary embolism (PE).
What is the current status of trial NCT04798261?
This trial is currently recruiting. The enrollment target is 1,500 participants. The study started on 2021-06-25. Estimated completion is 2028-02.
What conditions does trial NCT04798261 study?
This clinical trial studies the following conditions: Pulmonary Embolism.
What interventions are being tested in trial NCT04798261?
The interventions under investigation include: Indigo Aspiration System (DEVICE).
Who is sponsoring clinical trial NCT04798261?
This trial is sponsored by Penumbra, which has 25 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04798261 being conducted?
This trial has 20 study locations across California, Delaware, Florida, Georgia, Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Pulmonary Embolism
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
A Study of Mobility Outcomes in Post-Pulmonary Embolic Disease
RECRUITING · NA
-
Intervention to Improve Utilization of Extended Venous Thromboembolism Prophylaxis After Cancer Surgery
RECRUITING · NA
-
Clinical Utility of Portable Dynamic Chest X Ray (DDR) in the ICU
RECRUITING · NA
-
The PERSEVERE Study
RECRUITING · NA
-
Point-of-Care Ultrasound in Predicting Adverse Outcomes in Emergency Department Patients With Acute Pulmonary Embolism
RECRUITING
-
Supplemental Oxygen in Pulmonary Embolism (SO-PE)
RECRUITING · Early Phase 1
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.